Lyophilized powder: -20~-80°C for 1 year | Solution: -80°C for 6~12 month
Interferon‑alpha/beta receptor 1 (IFN‑ alpha / beta R1), also known as IFNAR1, are present in all tissues and even on the surface of most IFN-resistant cells. Isoform 1, isoform 2 and isoform 3 are expressed in the IFN-alpha sensitive myeloma cell line U266B1. Isoform 2 and isoform 3 are expressed in the IFN-alpha resistant myeloma cell line U266R. Isoform 1 is not expressed in IFN-alpha resistant myeloma cell line U266R. It interacts with STAT1 and STAT2, the interaction requires its phosphorylation at Tyr-466. It also interacts with FBXW11, the substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex.
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
10 μg | ¥ 820 | 5日内发货 | ||
50 μg | ¥ 2,480 | 5日内发货 | ||
500 μg | ¥ 12,100 | 5日内发货 | ||
1 mg | ¥ 17,400 | 5日内发货 |
IFNAR1 Protein, Rhesus macaque, Recombinant (His) 的其他形式现货产品:
产品描述 | Interferon‑alpha/beta receptor 1 (IFN‑ alpha / beta R1), also known as IFNAR1, are present in all tissues and even on the surface of most IFN-resistant cells. Isoform 1, isoform 2 and isoform 3 are expressed in the IFN-alpha sensitive myeloma cell line U266B1. Isoform 2 and isoform 3 are expressed in the IFN-alpha resistant myeloma cell line U266R. Isoform 1 is not expressed in IFN-alpha resistant myeloma cell line U266R. It interacts with STAT1 and STAT2, the interaction requires its phosphorylation at Tyr-466. It also interacts with FBXW11, the substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex. |
别名 | IFN-al, CRF2-1, IFN-alpha/beta receptor 1, human interferon-α receptor (HuIFN-α-Rec)10IFRC, α-type antiviral protein, AVP, Cytokine receptor family 2 member 1, IFN-alpha/beta R1, 干扰素, beta-type antiviral protein, IFN-α/β receptor 1, IFN-α/β R1, Cytokine receptor class-II member 1, β-type antiviral protein, human interferon-alpha receptor (HuIFN-alpha-Rec)10IFRC, alpha-type antiviral protein |
分子量 | 70-120 KDa, reducing conditions |
CAS No. | TMPJ-00331 |
Lyophilized powder: -20~-80°C for 1 year | Solution: -80°C for 6~12 month
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
IFNAR1 Protein, Rhesus macaque, Recombinant (His) TMPJ-00331 IFN-al CRF2-1 b-type antiviral protein IFN-a/b R1 human interferon-a receptor (HuIFN-a-Rec)10IFRC IFN-alpha/beta receptor 1 human interferon-α receptor (HuIFN-α-Rec)10IFRC α-type antiviral protein AVP Cytokine receptor family 2 member 1 IFN-alpha/beta R1 干扰素 beta-type antiviral protein IFN-α/β receptor 1 IFN-α/β R1 Cytokine receptor class-II member 1 IFN-a/b receptor 1 a-type antiviral protein β-type antiviral protein human interferon-alpha receptor (HuIFN-alpha-Rec)10IFRC alpha-type antiviral protein Inhibitor inhibitor inhibit